Position in ZTS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,521
-$1,916 QoQ
Shares Held
49
+6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,311
of 1,408 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Private Wealth Management Group, LLC holds $112,918 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #9 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,045 | $16,594 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
648 | $15,947 | |
| 3 | ALKS |
Alkermes plc.
|
283 | $14,827 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
27 | $14,629 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
83 | $13,988 | |
| 6 | INM |
InMed Pharmaceuticals Inc.
|
5,000 | $7,750 | |
| 7 | ANIK |
Anika Therapeutics, Inc.
|
522 | $7,636 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
64 | $7,100 |
All Filings in ZTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,521 | 49 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,437 | 46 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,794 | 54 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $16,241 | 111 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $20,585 | 132 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $22,227 | 135 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $19,388 | 119 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $23,640 | 121 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $20,629 | 119 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $27,073 | 160 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $33,355 | 169 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||